News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nanobiotix Appoints Dr. Bernd Muhlenweg as Head of Business Development



2/2/2011 9:16:32 AM

PARIS--(BUSINESS WIRE)--NANOBIOTIX the leading nanomedecine company focused on cancer therapy, announced today that its team has completed a comprehensive executive research and appointed Bernd M├╝hlenweg, PhD, as Head of Business Development.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES